Plasma proteomic studies have found that LCAT, GPX3, and leukotriene b4 can serve as potential biomarkers for thyroid cancer (16), and serum ISG15 and PLXNB2 can also serve as potential biomarkers (17). Here, GPX3 is linked to thyroid cancer.